EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY 4.0

Global Guidance for Dyslipidaemia Management in Adults: A Scoping Review

Andrew E Moran iD, Ashish Krishna iD, Lawrence Mbuagbaw iD, Kouamivi M Aboyibor iD, Rauell J Santos iD

Global Heart · 16.12.2025 · 20 (1) · 111

DOI: 10.5334/gh.1506 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Global Heart, online erschienen am 16.12.2025. Verfasst von Andrew E Moran und 4 weiteren Autor:innen. Beteiligte Einrichtung: Columbia University Irving Medical Center, New York, USA. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Disease Management, Dyslipidemias, Hypolipidemic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Dyslipidaemia is a leading preventable cause of global cardiovascular disease (CVD) burden, responsible for over four million deaths each year (1). A scoping review took a worldwide perspective and assessed recent World Health Organization (WHO) guidance documents, other national or regional guidelines, and randomized controlled trial evidence supporting dyslipidaemia management best practices.

Methods

Review of WHO guidance documents included aspects of dyslipidaemia management, but none provided a detailed and comprehensive approach. Of 11 non-WHO national or regional dyslipidaemia guidelines, nine met pre-defined inclusion criteria and were reviewed in depth. Structured electronic searches of MEDLINE found 27 systematic reviews of randomized clinical trials supporting dyslipidaemia management guideline priority topics.

Findings

This scoping review found overall consistency in the recommendations of regional and national dyslipidaemia guideline recommendations. Guidelines varied in terms of approach to assessing patient CVD risk and recommendations to treat with non-statin lipid-lowering therapy (LLT). Robust randomized trial evidence supports that a dyslipidaemia management guideline focuses on priority areas including approach to patient selection for LLT efficacy and safety, selection of initial LLT drugs and dose intensity, timing of LLT monitoring, and LLT management in specific high-risk groups (familial hypercholesterolemia, diabetes, chronic kidney disease, HIV and other inflammatory diseases, and older adults). Few regional or national guidelines provided practical implementation recommendations or cost-effectiveness assessments; less clinical trial evidence was found for the priority topic of equitable treatment.

Conclusion

Taking a global perspective, this scoping review describes the scope and depth of the current evidence base informing best practice management of dyslipidaemia for the primary and secondary prevention of CVD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesDisease ManagementDyslipidemiasHypolipidemic AgentsPractice Guidelines as TopicAdultHumansGlobal Health

Stichwörter der Autor:innen

DyslipidaemiaGuidelinesLipid lowering therapyScoping ReviewWorld Health Organisation

Substanzen

Hypolipidemic Agents

Autor:innen und Institutionen

  • Columbia University Irving Medical Center, New York, USA.
  • Resolve to Save Lives, New York, USA.
  • World Health Organization, Geneva, Switzerland.
  • McMaster University, Hamilton, Canada.

ORCID-Profile: Andrew E Moran, Ashish Krishna, Lawrence Mbuagbaw, Kouamivi M Aboyibor, Rauell J Santos

Förderung

  • World Health Organization

Zitieren

APA

Moran, A. E., Krishna, A., Mbuagbaw, L., Aboyibor, K. M., & Santos, R. J. (2025). Global Guidance for Dyslipidaemia Management in Adults: A Scoping Review. Global Heart, 20(1), 111. https://doi.org/10.5334/gh.1506

Vancouver

Moran AE, Krishna A, Mbuagbaw L, Aboyibor KM, Santos RJ. Global Guidance for Dyslipidaemia Management in Adults: A Scoping Review. Global Heart. 2025;20(1):111. doi:10.5334/gh.1506

BibTeX
@article{Moran2025,
  author = {Moran, Andrew E and Krishna, Ashish and Mbuagbaw, Lawrence and Aboyibor, Kouamivi M and Santos, Rauell J},
  title = {Global Guidance for Dyslipidaemia Management in Adults: A Scoping Review},
  journal = {Global Heart},
  year = {2025},
  volume = {20},
  number = {1},
  pages = {111},
  doi = {10.5334/gh.1506}
}
Kostenlos starten →